Centene Raises Full-Year Earnings, Revenue Guidance as Commercial Health Ratio Drops to 79.2%
Centene raised its 2026 full-year adjusted earnings per share and revenue guidance after a second-quarter profit that beat Wall Street estimates, driven by a sharp decline in the commercial health benefits ratio. The insurer lifted its adjusted EPS floor to over $4.80, up from a previous projection of $3.40, and widened its total revenue outlook to a range of $193.5 billion to $197.5 billion.
The commercial ratio fell to 79.2%, down from 90.6% a year ago, following aggressive rate hikes and membership reductions in the Marketplace book. Management noted that approximately $0.50 of the earnings guidance increase stems from non-recurring programmatic items in Medicare and commercial operations. Medicaid revenue grew 5% year-over-year to $22.8 billion, while Medicare segment revenue jumped 17%.
From the sources (3 posts)
@wallstengineCENTENE $CNC Q2’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $53.6B (Est. $47.62B) 🟢 🔹 Adj. EPS: $2.51 (Est. $1.08) 🟢 🔹 HBR: 89.6%; -340 bps YoY Raises FY26 Guide: 🔹 Revenue: $193.5B-$197.5B (Est. $191B) 🟢 🔹 Adj EPS: >$4.80 (Est. $3.52) 🟢 🔹 GAAP EPS
@candoriumCentene $CNC beat Wall Street's Q2 expectations The health insurer also raised its 2026 revenue outlook, driven by strength in its Medicaid and Marketplace businesses. #Centene #CNC #Earnings #Healthcare #StockMarket #WallStreet #investing
@finsee_main$CNC Q2 2026 earnings: The Turnaround is Real, but Aided by One-Timers Centene's brutal 2025 is officially in the rearview mirror. The aggressive medicine management prescribed a year ago—drastically repricing the Marketplace book and shed